Variceal gastrointestinal bleeding: epidemiology, pathogenesis, management and prophylaxis
DOI:
https://doi.org/10.47892/rgp.2025.453.2038Keywords:
Gastrointestinal Hemorrhage, Portal Hypertension, Liver Cirrhosis, Esophageal and Gastric VaricesAbstract
Variceal gastrointestinal bleeding is one of the main complications of portal hypertension in patients with cirrhosis. It affects those with decompensated cirrhosis, and its occurrence marks a turning point in the progression of liver disease. Despite therapeutic advances, challenges remain in comprehensive management, particularly in resource-limited settings. Treatment aims to control active bleeding, prevent early rebleeding, and reduce mortality. This review summarizes recent evidence on the pathophysiology, diagnosis, and updated management of variceal gastrointestinal bleeding, including emerging strategies such as early vasoactive therapy, rational use of transfusions, antibiotic prophylaxis, and the key role of timely endoscopy. It also highlights the importance of identifying clinically significant portal hypertension to prevent complications and improve clinical outcomes.
Downloads
Metrics
References
Alqahtani SA, Jang S. Pathophysiology and Management of Variceal Bleeding. Drugs. 2021;81(6):647-67.
Engelmann C, Clària J, Szabo G, Bosch J, Bernardi M. Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction. J Hepatol. 2021;75(Suppl 1):S49-66.
Baiges A, Hernández-Gea V. Management of Liver Decompensation in Advanced Chronic Liver Disease: Ascites, Hyponatremia, and Gastroesophageal Variceal Bleeding. Clin Drug Investig. 2022;42(Suppl 1):25-31.
Khan F, Tripathi D. Role of early transjugular intrahepatic portosystemic stent-shunt in acute variceal bleeding: An update of the evidence and future directions. World J Gastroenterol. 2021;27(44):7612-24.
Xu X, Tang C, Linghu E, Ding H, Chinese Society of Hepatology CMA, Chinese Society of Gastroenterology CMA, et al. Guidelines for the Management of Esophagogastric Variceal Bleeding in Cirrhotic Portal Hypertension. J Clin Transl Hepatol. 2023;11(7):1565-79.
Martell M, Coll M, Ezkurdia N, Raurell I, Genescà J. Physiopathology of splanchnic vasodilation in portal hypertension. World J Hepatol. 2010;2(6):208-20.
D’Amico G, Morabito A, D’Amico M, Pasta L, Malizia G, Rebora P, et al. Clinical states of cirrhosis and competing risks. J Hepatol. 2018;68(3):563-76.
Moreau R, Lebrec D. Molecular and Structural Basis of Portal Hypertension. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2023;21(8):2100-9.
De Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C, Abraldes JG, et al. Baveno VII – Renewing consensus in portal hypertension. J Hepatol. 2022;76(4):959-74.
Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatol Baltim Md. 2017;65(1):310-35.
Villanueva C, Albillos A, Genescà J, Garcia-Pagan JC, Calleja JL, Aracil C, et al. β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Lond Engl. 2019;393(10181):1597-608.
Mohanty A, Garcia-Tsao G. Management of acute variceal bleeding. Clin Liver Dis. 2024;23(1):e0176.
Gralnek IM, Camus Duboc M, Garcia-Pagan JC, Fuccio L, Karstensen JG, Hucl T, et al. Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2022;54(11):1094-120.
Lee PL, Yang KS, Tsai HW, Hou SK, Kang YN, Chang CC. Tranexamic acid for gastrointestinal bleeding: A systematic review with meta-analysis of randomized clinical trials. Am J Emerg Med. 2021;45:269-79.
Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila F, Soares-Weiser K, Mendez-Sanchez N, Gluud C, et al. Metaanalysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding - an updated Cochrane review. Aliment Pharmacol Ther. 2011;34(5):509-18.
de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C. Baveno VII – Renewing consensus in portal hypertension. J Hepatol. 2022;76(4):959-74.
Zhou X, Tripathi D, Song T, Shao L, Han B, Zhu J, et al. Terlipressin for the treatment of acute variceal bleeding: A systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2018;97(48):e13437.
Kaplan DE, Ripoll C, Thiele M, Fortune BE, Simonetto DA, Garcia-Tsao G, et al. AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis. Hepatology. 2024;79(5):1180-1211. doi: 10.1097/HEP.0000000000000647.
Instituto de Evaluación de Tecnología en Salud e Investigación, Seguro Social de Salud. Guia de Practica Clinica para la evaluación y manejo de la Hemorragia Digestiva Alta [Internet]. Lima: EsSalud; 2024 [citado el 8 de febrero de 2025]. Disponible en: https://ietsi.essalud.gob.pe/wp-content/uploads/2017/12/ GPC-Hemorragia-digestiva-alta-2024-version-corta.pdf
Diaz-Soto MP, Garcia-Tsao G. Management of varices and variceal hemorrhage in liver cirrhosis: a recent update. Ther Adv Gastroenterol. 2022;15:17562848221101712.
Tang S jiang. Ligation of Esophageal Varices. Video J Encycl GI Endosc. 2013;1(1):83-5.
García-Pagán JC, Saffo S, Mandorfer M, Garcia-Tsao G. Where does TIPS fit in the management of patients with cirrhosis? JHEP Rep Innov Hepatol. 2020;2(4):100122.
Morrison JD, Mendoza-Elias N, Lipnik AJ, Lokken RP, Bui JT, Ray CE, et al. Gastric Varices Bleed at Lower Portosystemic Pressure Gradients than Esophageal Varices. J Vasc Interv Radiol JVIR. 2018;29(5):636-41.
Aleem A, Shah H. Gastric Varices. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [citado 23 de febrero de 2025]. Disponible en: http://www.ncbi.nlm.nih.gov/ books/NBK570618/
Calmet F, Mohan P, Jalaeian H, Martin P. Management of Patients With Gastric Varices. Gastroenterol Hepatol. 2022;18(10):574-85.
Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatol Baltim Md. 1992;16(6):1343-9.
Lee EW, Eghtesad B, Garcia-Tsao G, Haskal ZJ, HernandezGea V, Jalaeian H, et al. AASLD Practice Guidance on the use of TIPS, variceal embolization, and retrograde transvenous obliteration in the management of variceal hemorrhage. Hepatol Baltim Md. 2024;79(1):224-50.
Henry Z, Patel K, Patton H, Saad W. AGA Clinical Practice Update on Management of Bleeding Gastric Varices: Expert Review. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2021;19(6):1098-1107.e1.
Ryou M, DeWitt JM, Das KK, Shami VM. AGA Clinical Practice Update on Interventional EUS for Vascular Investigation and Therapy: Commentary. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2023;21(7):1699-1705.e2.
Krige JEJ, Perold L, Jonas EG. Balloon tube tamponade for variceal bleeding: ten rules for safe usage. S Afr J Surg. 2021;59(4):198-199.
Escorsell À, Pavel O, Cárdenas A, Morillas R, Llop E, Villanueva C, et al. Esophageal balloon tamponade versus esophageal stent in controlling acute refractory variceal bleeding: A multicenter randomized, controlled trial. Hepatol Baltim Md. 2016;63(6):1957-67.
Higuera-de-la-Tijera F, Noble-Lugo A, Crespo J, Albillos A, Montaño-Loza AJ, Cano-Contreras AD, et al. Consenso mexicano sobre abordaje y tratamiento de la hemorragia variceal aguda. Rev Gastroenterol México. 2025;90(3):451-73.
Hwang JH, Shergill AK, Acosta RD, Chandrasekhara V, Chathadi KV, Decker GA, et al. The role of endoscopy in the management of variceal hemorrhage. Gastrointest Endosc. 2014;80(2):221-7.
Park JH, Jun DW, Choi J, Koh DH, Yoon JH, Lee KN, et al. LowDose Propranolol as Secondary Prophylaxis for Varix Bleeding Decreases Mortality and Rebleeding Rate in Patients with Tense Ascites. J Clin Med. 2019;8(5):573.
Sharma S, Agarwal S, Gunjan D, Kaushal K, Anand A, Mohta S, et al. Long-term Outcomes with Carvedilol versus Propranolol in Patients with Index Variceal Bleed: 6-year Follow-up Study. J Clin Exp Hepatol. 2021;11(3):343-53.
Lin LL, Du SM, Fu Y, Gu HY, Wang L, Jian ZY, et al. Combination therapy versus pharmacotherapy, endoscopic variceal ligation, or the transjugular intrahepatic portosystemic shunt alone in the secondary prevention of esophageal variceal bleeding: a meta-analysis of randomized controlled trials. Oncotarget. 2017;8(34):57399-408.
Pfisterer N, Unger LW, Reiberger T. Clinical algorithms for the prevention of variceal bleeding and rebleeding in patients with liver cirrhosis. World J Hepatol. 2021;13(7):731-46.
Moitinho E, Escorsell A, Bandi JC, Salmerón JM, García-Pagán JC, Rodés J, et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology. 1999;117(3):626-31.
Marasco G, Dajti E, Ravaioli F, Alemanni LV, Capuano F, Gjini K, et al. Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients. Hepatol Int. 2020;14(5):850-7.
Villa E, Bianchini M, Blasi A, Denys A, Giannini EG, Gottardi A de, et al. EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis. J Hepatol. 2022;76(5):1151-84.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 P. Martin Padilla-Machaca, Sergio Padilla Gonzales, Maria Grazia Venturelli Romero, Maria Cecilia Cabrera Cabrejos
This work is licensed under a Creative Commons Attribution 4.0 International License.
Revista de Gastroenterología del Perú by Sociedad Peruana de Gastroenterología del Perú is licensed under a Licencia Creative Commons Atribución 4.0 Internacional..
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).
2022 